Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

A. A. Ashrani, D. A. Gabriel, J. L. Gajewski, D. R. Jacobs, D. J. Weisdorf, N. S. Key

    Research output: Contribution to journalLetter

    14 Scopus citations
    Original languageEnglish (US)
    Pages (from-to)825-828
    Number of pages4
    JournalBone marrow transplantation
    Volume38
    Issue number12
    DOIs
    StatePublished - Dec 1 2006

    ASJC Scopus subject areas

    • Hematology
    • Transplantation

    Cite this